跳至主要内容
临床试验/SLCTR/2018/027
SLCTR/2018/027尚未招募4 期

Celecoxib as adjunctive therapy in depression: a double- blind, randomized controlled trial

Faculty of Medicine, University of Kelaniya0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Males and females above 18 years
  • 2. Diagnosis of a depressive episode made by a consultant psychiatrist according to ICD-10 criteria
  • 3. Hamilton Depression Rating Scale score (HDRS) > 14 for the current episode

排除标准

  • 1. Previous diagnosis of Bipolar Affective Disorder, Schizophrenia or Schizoaffective disorder
  • 2. Depression due to chronic medical illnesses
  • 3. Organic brain disease
  • 4. Dependent on alcohol and other psychoactive substances
  • 5. Associated psychotic symptoms, strong suicidal ideas
  • 6. Undergone ECT during last 2 months
  • 7. Use of psychological treatment for the current episode
  • 8. Use of more than one antidepressant, mood stabilisers or antipsychotic medication for current episode
  • 9. Use of a higher dose of antidepressants than that recommended by British National Formulary (BNF) for the current episode.
  • 10. Ischemic Heart Disease, Stroke and Gastro intestinal bleeding due to Peptic Ulcers
  • 11. Pregnancy and Lactation
  • 12. Unable to give informed consent

研究者

相似试验